+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 14Years - 89Years
FEMALE
Healthy Volunteers
ID05989581

Treatment of American Heart AssociationAmerican College of Cardiology Stage 1 Hypertension in Pregnancy A Randomized Control Trial

Led by University of Alabama at Birmingham · Updated on 2026-08-11

74

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to provide preliminary data on whether treating stage 1 hypertension in pregnancy influences maternal and neonatal outcomes. The study focuses on pregnant patients with stage 1 hypertension and evaluates if lowering blood pressure to below 13080 mmHg affects the birthweight percentile of their newborns. It is a randomized controlled trial designed to support a larger multicenter study. Participants will be randomly assigned to one of two groups one targeting a blood pressure goal below 13080 mmHg with active treatment, and the other receiving usual care, where treatment is given only if blood pressure reaches 14090 mmHg or higher. The active treatment involves prescribing labetalol or nifedipine, with dosing adjusted weekly as needed to maintain the targeted blood pressure. After delivery and a 6-week postpartum visit, participants will transition to their primary care provider for ongoing blood pressure management. During the study, blood pressures will be monitored at least weekly by study team members who coordinate care with clinical providers. The primary outcome measured is the neonatal birthweight percentile at delivery. Participants will be followed through delivery and the postpartum period, with safety and treatment effectiveness assessed throughout. The total study duration extends until December 31, 2026, allowing thorough observation of maternal and neonatal outcomes.

CONDITIONS

Brief Title

Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project

Research Team

D

Donna Dunn, PhD

J

Jhana Plump

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here